Antibody Mediated Prevention trial: Where to from here?


Back Registration Programme Help desk
Antibody Mediated Prevention trial: Where to from here? Thursday, February 4, 2021 • RT03 • 5:30 PM > 7:00 PM • Antibody Mediated Prevention trial: Where to from here? • Live channel 1 This session is designed to unpack some of the detail on the late breaking results of the AMP trial. They will delve more deeply into how well the VRC01 antibody protected WSM and MSM from HIV acquisition and how this will inform future antibody mediated prevention trials in the future. 5:30 PM • RT03.01 • History of VRC01 – Derivation and preclinical studies See abstract 5:40 PM • RT03.02 • Who took part in AMP and how did it go for them? See abstract 5:50 PM • RT03.03 • Study design of AMP See abstract 6:00 PM • RT03.04 • Relationship between ID50 and acquisition See abstract 6:10 PM • RT03.05 • What does this mean for antibody mediated prevention in the future? See abstract 6:20 PM • RT03.06 • Panel discussion See abstract